4.7 Article

Epigenetic Modifications in Double-Strand Break DNA Damage Signaling and Repair

期刊

CLINICAL CANCER RESEARCH
卷 16, 期 18, 页码 4543-4552

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1078-0432.CCR-10-0513

关键词

-

类别

资金

  1. Canadian Institutes of Health Research (CIHR) [MOP-14308/64289]
  2. National Institutes of Health (NIH) [RO1 GM60443]
  3. Leukemia and Lymphoma Society
  4. Canada Research Chair

向作者/读者索取更多资源

Factors involved in the cellular response to double-strand break (DSB) DNA damage have been identified as potential therapeutic targets that would greatly sensitize cancer cells to radiotherapy and genotoxic chemotherapy. These targets could disable the repair machinery and/or reinstate normal cell-cycle checkpoint leading to growth arrest, senescence, and apoptosis. It is now clear that a major aspect of the DNA damage response occurs through specific interactions with chromatin structure and its modulation. It implicates highly dynamic posttranslational modifications of histones that are critical for DNA damage recognition and/or signaling, repair of the lesion, and release of cell-cycle arrest. Therefore, drugs that target the enzymes responsible for these modifications, or the protein modules reading them, have very high therapeutic potential. This review presents the current state of knowledge on the different chromatin modifications and their roles in each step of eukaryotic DSB DNA damage response. Clin Cancer Res; 16(18); 4543-52. (c) 2010 AACR.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据